TY - JOUR
T1 - Immune responses to weakly immunogenic virally induced tumors II. Suppressive effects of the in vivo carried tumor YAC
AU - Devens, B.
AU - Galili, Naomi
AU - Deutsch, Ofra
AU - Naor, D.
AU - Klein, Eva
PY - 1978/8
Y1 - 1978/8
N2 - Unprimed spleen cells from A and C57BL/6 mice could not produce cytotoxic responses to their syngeneic tumors: a Moloney virus‐induced in vitro subline YAC‐1 and a Rauscher virus‐induced in vitro subline RBL5, respectively. Spleen cells from A and C57BL/6 mice immunized with YAC‐1 or RBL5 (which cross‐react serologically) generated significant syngeneic cytotoxicities after cultivation in vitro. The in vivo carried tumor of A mice, unlike the in vitro sublines, could not stimulate a priming effect. In contrast, YAC stimulated the formation of suppressor cells in both A and C57BL/6 mice. The suppressor cells abrogated the priming effect of the syngeneic tumors, but not the priming effect of the allogeneic tumors. Furthermore, YAC did not suppress normal allogeneic anti‐tumor responses. The theoretical and the practical implications of these studies are discussed.
AB - Unprimed spleen cells from A and C57BL/6 mice could not produce cytotoxic responses to their syngeneic tumors: a Moloney virus‐induced in vitro subline YAC‐1 and a Rauscher virus‐induced in vitro subline RBL5, respectively. Spleen cells from A and C57BL/6 mice immunized with YAC‐1 or RBL5 (which cross‐react serologically) generated significant syngeneic cytotoxicities after cultivation in vitro. The in vivo carried tumor of A mice, unlike the in vitro sublines, could not stimulate a priming effect. In contrast, YAC stimulated the formation of suppressor cells in both A and C57BL/6 mice. The suppressor cells abrogated the priming effect of the syngeneic tumors, but not the priming effect of the allogeneic tumors. Furthermore, YAC did not suppress normal allogeneic anti‐tumor responses. The theoretical and the practical implications of these studies are discussed.
UR - http://www.scopus.com/inward/record.url?scp=0018126307&partnerID=8YFLogxK
U2 - 10.1002/eji.1830080807
DO - 10.1002/eji.1830080807
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 699954
AN - SCOPUS:0018126307
SN - 0014-2980
VL - 8
SP - 573
EP - 578
JO - European Journal of Immunology
JF - European Journal of Immunology
IS - 8
ER -